Related references
Note: Only part of the references are listed.Fasting plasma glucose variability in midlife and risk of Parkinson's disease: A nationwide population-based study
H. S. Chung et al.
DIABETES & METABOLISM (2021)
Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2021)
Post-stroke Hyperglycemia in Non-diabetic Ischemic Stroke is Related With Worse Functional Outcome: A Cohort Study
Jin A. Yoon et al.
ANNALS OF REHABILITATION MEDICINE-ARM (2021)
Hyperglycemia Drives Stent Restenosis in STEMI Patients
Pasquale Mone et al.
DIABETES CARE (2021)
Glycemic variability and the risk of nonalcoholic fatty liver disease : A nationwide population-based cohort study
So-hyeon Hong et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes
Chun-Pai Yang et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Burden of Peripheral Artery Disease on Mortality and Incident Cardiovascular Events The Multi-Ethnic Study of Atherosclerosis
Jonathan T. Unkart et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2020)
Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial
Chang-Sheng Sheng et al.
DIABETES CARE (2020)
Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
Antonio Ceriello et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Long-term tracking of fasting blood glucose variability and peripheral artery disease in people without diabetes
Xiu-Ting Sun et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study
Baris Gencer et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2020)
Effects of long-term glycemic variability on incident cardiovascular disease and mortality in subjects without diabetes A nationwide population-based study
Ji Hee Yu et al.
MEDICINE (2019)
Update on peripheral artery disease: Epidemiology and evidence-based facts
Jun Shu et al.
ATHEROSCLEROSIS (2018)
Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
Daisuke Matsutani et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial
Jin J. Zhou et al.
DIABETES CARE (2018)
Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study
Jung A. Kim et al.
DIABETES CARE (2018)
Epidemiology of peripheral artery disease in Europe: VAS Educational Paper
Dan-Mircea Olinic et al.
INTERNATIONAL ANGIOLOGY (2018)
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
Bernard Zinman et al.
DIABETOLOGIA (2018)
Socioeconomic Status and Incidence of Hospitalization With Lower-Extremity Peripheral Artery Disease: Atherosclerosis Risk in Communities Study
Priya Vart et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population
Anxin Wang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis
Catherine Gorst et al.
DIABETES CARE (2015)
Visit-to-Visit Glucose Variability Predicts the Development of End-Stage Renal Disease in Type 2 Diabetes 10-Year Follow-Up of Taiwan Diabetes Study
Ya-Fei Yang et al.
MEDICINE (2015)
Socioeconomic Inequality and Peripheral Artery Disease Prevalence in US Adults
Reena L. Pande et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)
Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial
Yoichiro Hirakawa et al.
DIABETES CARE (2014)
Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population
Mark R. Nehler et al.
JOURNAL OF VASCULAR SURGERY (2014)
Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty
Satinder Singh et al.
VASCULAR MEDICINE (2014)
Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study
Giuseppe Penno et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Glycemic Memories and the Epigenetic Component of Diabetic Nephropathy
Samuel T. Keating et al.
CURRENT DIABETES REPORTS (2013)
Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories
Jeffrey S. Berger et al.
JOURNAL OF VASCULAR SURGERY (2013)
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
F. Gerald R. Fowkes et al.
LANCET (2013)
Cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients with peripheral artery disease
Luis Henrique Canani et al.
DIABETOLOGY & METABOLIC SYNDROME (2013)
Hyperglycemia in Nondiabetic Patients Presenting With Acute Myocardial Infarction
Binita Shah et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2012)
The Influence of Glycemic Control on the Prognosis of Japanese Patients Undergoing Percutaneous Transluminal Angioplasty for Critical Limb Ischemia
Mitsuyoshi Takahara et al.
DIABETES CARE (2010)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults.
Elizabeth Selvin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients
Antonio Ceriello et al.
DIABETES (2008)
Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Ethnic-specific prevalence of peripheral arterial disease in the United States
Matthew A. Allison et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2007)
Gliclazide protects human islet beta-cells from apoptosis induced by intermittent high glucose
S. Del Guerra et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2007)
Close relationship between sympathetic activation and coronary microvascular dysfunction during acute hyperglycemia in subjects with atherosclerotic risk factors
Yasuyoshi Takei et al.
CIRCULATION JOURNAL (2007)
Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta
Kosuke Azuma et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction
Ludovica Piconi et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2006)
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes
L Monnier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies
EB Levitan et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cell - The role of protein kinase C and NAD(P)H-oxidase activation
L Quagliaro et al.
DIABETES (2003)
Share Paper
